Breast Cancer Frequency Rate Shift Toward Younger Age In IRAQ

Authors(2) :-Abdulghani Mohamed Alsamarai, Shilan Salah Abdula

Breast cancer in Arab countries present at earlier age than in Western countries and early diagnosis may contribute to better treatment outcome.
Aim: To determine the frequency rate in different age groups.
Patients and methods: A total of 148 breast cancer cases included in the study. The analysis of variables performed with stratification of 10 years age interval. 
Results: Age distribution of breast cancer indicated that 20.3% of cases were with age of ≤20 years and 14.9% were with age of 16-18 years. In addition more than half of cases [52.7%] were with age of less than 30 years. Furthermore, 79.7% of breast cancer cases were in women ≤40 years of age.  Only 5.4% of cases were with age of > 45 years. Odd ratio confirmed a significant association between age and breast cancer development in our study cohort.  The highest frequency was in women with age of 21-30 years, followed by those with age of 31-40 years. Age of women with breast cancer significantly influences the CEA and ER mean serum values whether the analysis performed on group or individual stratification. In addition, P53 mean serum level in women with breast cancer was significantly different when the analysis performed on individual stratification, however, non-significant differences was achieved between age group. The same pattern was demonstrated for CA 27-29 and PR.       
Conclusion: Age at diagnosis was with two decades earlier than that in Western countries.

Authors and Affiliations

Abdulghani Mohamed Alsamarai
Tikrit University College of Medicine, Tikrit, Iraq
Shilan Salah Abdula
Tikrit University College of Medicine, Tikrit, Iraq

Breast cancer, Pollution, Frequency, CA 15-3, CA 27-29, PR, ER, P53, CEA.

  1. El Saghir NS, Khalil MK, Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg 2007; 5:225-33.
  2. Iraqi national cancer research center, Brief historical introduction, establishing the breast & cervical cancer research unit and the Iraqi National Cancer Research Center/Program, 2013.
  3. Alwan NA . Breast cancer: demographic characteristics and clinico- pathological presentation of patients in Iraq. East Mediterr Health J 2010;16: 1159-64.
  4. Alwan N. Iraqi initiative of a regional comparative breast cancer research project in the Middle East. J Cancer Biol Res 2014;2:1016.
  5. Globocan. Breast cancer incidence and mortality worldwide, 2008. International Agency for Research on Cancer; 2010.
  6. Al-Hashimi MM, Wang XJ. Breast cancer in Iraq, incidence trends from 2000-2009. Asian Pacific J Cancer Prev 2014;15:281-286.
  7. WHO. National Cancer Control Programs. Policies and managerial guidelines, 2 nd. Ed.Geneva, World Health Organization,2002.
  8. Najjar H, Easson A. Age at diagnosis of breast cancer in Arab nations. Int J Surg 2010;8:448-452.
  9. Swanson GM, Lin CS. Survival patterns among younger women with breast cancer: the effect of age, race, stage, and treatment. J Natl Cancer Inst Monogr 1994;16:69-77.
  10. Al Diab A, Qureshi S, Al Saleh KA, AlQahtani FH, Aleem A, et al . Review on breast cancer in the Kingdom of Saudi Arabia. Midd East Sci Res 2013;14:532-543.
  11. Al-Alwan N, Al-Rufaee FL. Comparative demographic and clinicopathological study on the behavior of mammary carcinoma in three Iraqi governorates (Baghdad, Hilla and Karbala). J Fac Med Baghdad 2010;52:419-423.
  12. Cox B, Richardson A, Grasham P, Gislefoss RE, Jellum E, Rollag H. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study.Br J Cancer 2010;102:1665-1669.
  13. Hosseini MS, Arab M, Honar BN, Noghabaei G, Safaei N, et al. Age specific incidence rate change at breast cancer and its different histopathologic subtypes in Iran and Western countries. Pak J Med Sci 2013;29:1354-1357.
  14. Ries LAG, Melbert D, Kraocho M, Stinchcomb DG, Howlader N, Horner MJ. SEER cancer statistic review, 1997-2005, National Cancer Institute, Bethesda, MD, 2009.
  15. Majid RA, Mohamed HA, Hassan HA, Abdulmahdi W, Rashed R, Hughson M. A population based study of Kurdish breast cancer in Northern Iraq: hormone receptor and HER2 status. A comparison with Arabic women and United States SEER data. BMC Women's Health 2012;12:16.
  16. Zangana AM, Garota SA. Risk factors of breast cancer in a sample of Kurdish women of Kurdish Region- Iraq: a comparative study between pre-menopausal and post-menopausal women. Zanco J Med Sci 2012;16:262-267.
  17. Chasib TJ, Hawaz M, Jasim NH. Evaluation of the estrogen and progesterone receptors in female breast cancer in respect to age, grade and stage. Basrah J Surg2013;19:9-14.
  18. Lafta RK, Saeed EQ, Isa SA. Risk factors of breast cancer among women ( a sample from Baghdad).Iraqi J Com Med 2013;1:1-6.
  19. Mahmoud MM. Breast cancer in Kirkuk city, hormone receptors status (estrogen and progesterone) and Her2/Neu and their correlation with other pathologic prognostic variables. Diyala J Med 2014;6:1-14.
  20. Arzu Jalaly . Biochemical Markers in Patients with Breast Cancer, 2015, Ph D Thesis, Tikrit University College of Medicine.
  21. Results of the Iraqi Cancer Registry. Iraqi Cancer Registry Center. Iraqi Cancer Board, Ministry of Health, 2004.
  22. Al-Alwan N. A. S.: Clinicopathological evaluation of nuclear DNA ploidy and hormone receptor contents in breast tumors. Ph.D. thesis submitted to the college of medicine and the committee of post graduate studies of the University of Baghdad, 1998.
  23. Al-Alwan N. A.: Iraqi breast cancer: A review on Patient Demographic Characteristics and Clinico-Pathological Presentation. Proceeding from the 27th San Antonio Breast Cancer Symposium. Dec.8-11, 2004. San Antonio, USA.
  24. Al-Anbari S. S.: Correlation of the clinicopathological presentations in Iraqi breast cancer patients with the findings of biofield breast cancer diagnostic system (BDS), HER-2 and Ki-67 immunohistochemical expression, a thesis submitted to the college of medicine and the committee of post graduate studies of the University of Baghdad in partial fulfillment of the requirement for the degree of Ph. D. in Pathology.2009.
  25. Hasoon S.: Correlation of the findings of biofield breast cancer diagnostic system (BDS) with clinicopathological parameters of mammary carcinoma in Iraq, a thesis submitted to Iraqi Board of Medical specialties in partial fulfillment of the requirement for the degree of fellowship of the Iraqi Board of Medical Specialization in Pathology, 2007.
  26. Ameen A.: Breast cancer in Iraqi female patients a clinicopathological and immunohistochemical study, a thesis submitted to Iraqi Board of Medical specialties in partial fulfillment of the requirement for the degree of fellowship of the Iraqi Board of Medical Specialization in Pathology, 2009.
  27. Ahmad N. Y.: Current status of breast cancer in Kurdish women in Erbil (Kurdistan of Iraq). Zanco J for medical sciences, 2004; 8: 13-23.
  28. Leong SPL, Shen ZZ, Liu TJ, Agarwal G, Tajima T, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg 2010;34:2308-2324.
  29. Al-Alwany SHM, Ali SM. Molecular detection of human cytomegalovirus in Iraqi patients with breast cancer. Intern Nation J Advan Biol Res 2013;3:454-459.
  30. Tarawneh M, Nimri O, Arkoob K, et al. Cancer Incidence in Jordan 2009. Non-Communicable Diseases Directorate, Jordan Cancer Registry. Ministry of Health, 2009.
  31. Amin TT, Al Mulhim AR, Al-Meqihwi A . Breast cancer knowledge, risk factors and screening among adult Saudi women in a primary health care setting. Asian Pac J Cancer Prev 2009; 10: 133-8.
  32. Al-Rikabi A, Husain S. Increasing prevalence of breast cancer among Saudi patients attending a tertiary referral hospital: a retrospective epidemiologic study. Croatian Medical J 2012; 53: 239.
  33. Yousuf SA, Al-Amoudi SM, Nicolas W, et al. Do Saudi Nurses in Primary Health Care Centers have Breast Cancer Knowledge to Promote Breast Cancer Awareness?. Asian Pac J Cancer Prev 2012;13: 4459-64.
  34. Boder JM, Abdalla E, Fathi B, et al. Breast cancer patients in Libya: comparison with European and central African patients. Oncology Letters 2011; 2: 323-30.
  35. Montazeri A, Vahdaninia M, Harirchi I, et al. Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med 2008; 7: 6.
  36. Asadzadeh VF, Broeders MJ, Mousavi SM, et al . The effect of demographic and lifestyle changes on the burden of breast cancer in Iranian women: a projection to 2030. The Breast 2012;22: 277-81.
  37. Kooshyar MM, Nassiri M, Mahdavi M, et al. Identification of Germline BRCA1 Mutations among Breast Cancer Families in Northeastern Iran. Asian Pac J Cancer Prev 2013;14:4339-45.
  38. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. The Lancet 2011; 377:127-38.
  39. World Health Statistics. By World Health Organization. Electronic version.;2008.
  40. Elgaili EM, Abuidris DO, Rahman M, et al. Breast cancer burden in central Sudan. Int J women’s health 2010; 2: 77.
  41. El-Zaemey S, Nagi N, Fritschi L, et al. Breast cancer among Yemeni women using the National Oncology Center Registry 2004-2010. Cancer Epidemiol 2012;36:249-53.
  42. Al-Madouj A, Eldali A, Al-Zahrani AS, et al. Ten year cancer incidence among Nationals of the GCC states 1998-2007, Executive Board Of Health, Ministers’ Council For The Gulf, Cooperation Council State, Gulf Center for Cancer Control and Prevention, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, 2011.
  43. Saadat S. Can we prevent breast cancer?. Int J Health Sciences 2008; 2:167.
  44. Tarawneh M, Arqoub K, Sharkas G. Epidemiology and Survival Analysis of Jordanian Female Breast Cancer Patients Diagnosed from 1997 to 2002. Middle East J Cancer 2011; 2: 71-80.
  45. Lakkis NA, Adib SM, Osman MH, et al. Breast cancer in Lebanon: incidence and comparison to regional and Western countries. Cancer Epidemiol 2010;34: 221-5.
  46. Hou N, Huo D. A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase. Breast Cancer Res Treat 2013;138:633-41.
  47. Daubisse ML, Delafosse P, Boitard JB, et al. Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Annals Oncol 2011;22:329-34.
  48. Office for National Statistics. Registrations of cancer diagnosed in 2011, England, London. 2013.
  49. Australian Institute of Health. Breast cancer in Australia: an overview. Cancer series no. 71. Cat. no. CAN 67. Canberra: AIHW, 2012.
  50. United Nation, Department of Economic and Social Affairs, Population Division, Population Estimates and Projections Section. , UN, World Population Prospects: The 2012 Revision.
  51. Al-Azzawi SN. Depleted Uranium radioactive contamination in Iraq: an Retrieved 1-10-2015.
  52. Al-rudainy LA, Ajeel NA, Al- saad HT. Depleted Uranium and incidence of cancer in Basrah: a preliminary ecological study.Med J Basrah Univ 2009;27:1-6.
  53. Yacoub AAH, Ajeel NAH, Al-Waswasy MK. Incidence and pattern of malignant disease (excluding leukemia) during 1990–1997. The Medical Journal of Basrah University 1999; 17: 35-41.
  54. Habib OS, Al- Ali Jk, Al-Wiswasy MK, Ajeel NAH. Theburden of cancer in Basrah: the state of the art – first report [Online]. 2005.
  55. Al-Azzawi SN. Depleted Uranium Radioactive Contamination In Iraq: An Overview. Presented at The 3rd ICBUW International Conference Hiroshima,2006.
  56. Al-Azzawi SN, Maarouf, B., and Hussein, S. Environmental consequences resulted from the use of DU weapons on soil and air at selected areas in al-Basrah governorate. Journal of Engineering 2002; 7 (1): 234 – 239.
  57. Assi HA, Khoury KE, Dbuk H, Khalil LE, Mouhieddine TH, El Saghir NS. Epidemiology and prognosis of breast cancer in young women. J Thorac Dis 2013;5:S2-S8.
  58. Anders CK, Johnson R, Litton J, et al. Breast cancer before age 40 years. Semin Oncol 2009;36:237-49.
  59. Morrison DH, Rahardja D, King E, Peng Y, Sarode VR. Tumor biomarker expression relative to age and molecular subtypes of invasive breast cancer. Br J Cancer2012;106:382-387.
  60. Walker RA, Lees E, Webb MB, Dearing SJ. Breast carcinomas in occurring in young women (<35 years) are different. Br J Cancer 1996;74:1796-1800.
  61. Colleoni M, Rotmensz N, Robertson C, et al. Very young women (<35 years) with operable breast cancer: feature of disease at presentation. Ann Oncol 2002; 13:273-279.

Publication Details

Published in : Volume 1 | Issue 5 | September-October 2015
Date of Publication : 2015-10-30
License:  This work is licensed under a Creative Commons Attribution 4.0 International License.
Page(s) : 407-414
Manuscript Number : IJSRSET151553
Publisher : Technoscience Academy

Print ISSN : 2395-1990, Online ISSN : 2394-4099

Cite This Article :

Abdulghani Mohamed Alsamarai, Shilan Salah Abdula, " Breast Cancer Frequency Rate Shift Toward Younger Age In IRAQ, International Journal of Scientific Research in Science, Engineering and Technology(IJSRSET), Print ISSN : 2395-1990, Online ISSN : 2394-4099, Volume 1, Issue 5, pp.407-414, September-October-2015.
Journal URL :

Article Preview